CLINICAL_TRIALS
trial_result
· 2020-02-28
Clinical Trial Update: Study of Dupilumab in Adult Participants With Active Eosinophilic Esophagitis (EoE) [Phase 2]
Summary
Phase 2 trial update for dupilumab in adults with active eosinophilic esophagitis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Regeneron Pharmaceuticals | Conditions: Eosinophilic Esophagitis | Phase 2 | Status: COMPLETED | Results posted: 2020-02-28